Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy [electronic resource].
By: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2005 : Lyon, France).
Contributor(s): World Health Organization | International Agency for Research on Cancer | ebrary, Inc
.
Series: IARC monographs on the evaluation of carcinogenic risks to humans ; v. 91.Publisher: Lyon, France : Geneva : International Agency for Research on Cancer ; Distributed by WHO Press, 2007Description: ix, 528 p. : ill.Subject(s): Progestational hormones -- Carcinogenicity | Progestational hormones -- Side effects | Catechol estrogens -- Carcinogenicity | Estrogen -- Carcinogenicity | Catechol estrogens -- Side effects | Estrogen -- Side effects | Contraception -- Complications | Menopause -- Hormone therapy -- Complications | Chemical carcinogenesis | Cancer -- Risk factors | Women -- Diseases -- Risk factors | Oral contraceptives -- CarcinogenicityGenre/Form: Electronic books.Online resources: An electronic book accessible through the World Wide Web; click to view
At head of title: World Health Organization, International Agency for Research on Cancer.
"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005."
Includes bibliographical references and cumulative index.
TSLHHL
Electronic reproduction. Palo Alto, Calif. : ebrary, 2009. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.